Cargando…
Targeting BMI-1-mediated epithelial–mesenchymal transition to inhibit colorectal cancer liver metastasis
Liver is the most common metastatic site for colorectal cancer (CRC), there is no satisfied approach to treat CRC liver metastasis (CRCLM). Here, we investigated the role of a polycomb protein BMI-1 in CRCLM. Immunohistochemical analysis showed that BMI-1 expression in liver metastases was upregulat...
Autores principales: | Xu, Zhiyao, Zhou, Zhuha, Zhang, Jing, Xuan, Feichao, Fan, Mengjing, Zhou, Difan, Liuyang, Zhenyu, Ma, Ximei, Hong, Yiyang, Wang, Yihong, Sharma, Sherven, Dong, Qinghua, Wang, Guanyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148062/ https://www.ncbi.nlm.nih.gov/pubmed/34094833 http://dx.doi.org/10.1016/j.apsb.2020.11.018 |
Ejemplares similares
-
miR-200c Modulates the Pathogenesis of Radiation-Induced Oral Mucositis
por: Tao, Jingjing, et al.
Publicado: (2019) -
Quercetin Prevents Radiation-Induced Oral Mucositis by Upregulating BMI-1
por: Zhang, Jing, et al.
Publicado: (2021) -
BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells
por: Jiang, Zhong-Yang, et al.
Publicado: (2023) -
Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011) -
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
por: Wang, Guanyu, et al.
Publicado: (2017)